NLRC5 and central nervous system cancer: Zong et al. found that highly-expressed SCAMP1 in glioma facilitated malignant progression and suppressed apoptosis of glioma cells by regulating the miR-499a-5p/LMX1A/NLRC5 pathway, which was associated with poor overall survival32.